MOLECULAR ASPECTS OF CHEMICAL CARCINOGENESIS - THE ROLES OF ONCOGENES AND TUMOR-SUPPRESSOR GENES

被引:83
|
作者
STANLEY, LA
机构
[1] Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, Mansfield Road
关键词
TUMORIGENESIS; ONCOGENES; TUMOR SUPPRESSOR GENES; RAS ACTIVATION;
D O I
10.1016/0300-483X(94)02991-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The observation that oncogenes are frequently activated in human tumours raises the question of whether these genes are involved in chemical carcinogenesis. H-ras activation is probably an initiating event in mouse skin and rat mammary gland systems. The H-ras oncogene is also important in mouse liver tumours; in mouse lung the K-ras gene is commonly activated. In both, the mutations observed are usually those predicted from the adduct-forming properties of the carcinogen. Among non-ras oncogenes, only raf and neu have been detected in experimental tumours. Tumour suppressor genes are frequently inactivated in human tumours. Searches for such phenomena in animal tumours have generally had disappointing results. p53 and Rb gene alterations are rarely observed in chemically-induced tumours. The reason may be that unknown tumour suppressor genes are involved in animal tumour development. Several novel genes have been identified using animal tumour susceptibility models. Thus, ras genes are important in chemical carcinogenesis, but as the methodology for studying other genes improves, their roles will be seen in perspective.
引用
收藏
页码:173 / 194
页数:22
相关论文
共 50 条
  • [1] Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
    Kontomanolis, Emmanuel N.
    Koutras, Antonios
    Syllaios, Athanasios
    Schizas, Dimitrios
    Mastoraki, Aikaterini
    Garmpis, Nikolaos
    Diakosavvas, Michail
    Angelou, Kyveli
    Tsatsaris, Georgios
    Pagkalos, Athanasios
    Ntounis, Thomas
    Fasoulakis, Zacharias
    ANTICANCER RESEARCH, 2020, 40 (11) : 6009 - 6015
  • [2] Oncogenes and tumor-suppressor genes in mesothelioma - A synopsis
    Lechner, JF
    Tesfaigzi, J
    Gerwin, BI
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 : 1061 - 1067
  • [3] ONCOGENES AND TUMOR-SUPPRESSOR GENES - 2 DIFFERENT LOOKS OF THE SAME GENE
    CALIN, G
    ONCOLOGY REPORTS, 1994, 1 (05) : 987 - 991
  • [4] PROGNOSTIC-SIGNIFICANCE OF ONCOGENES AND TUMOR-SUPPRESSOR GENES IN HUMAN MALIGNANCY
    SPANDIDOS, DA
    LILOGLOU, T
    FIELD, JK
    STEM CELLS, 1993, 11 (03) : 194 - 198
  • [5] ONCOGENES, PROTOONCOGENES, AND TUMOR-SUPPRESSOR GENES IN ACUTE MYELOGENOUS LEUKEMIA
    HIJIYA, N
    GEWIRTZ, AM
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1995, 17 (02) : 101 - 112
  • [6] TUMOR-SUPPRESSOR GENES IN MOLECULAR MEDICINE
    HOPPESEYLER, F
    BUTZ, K
    CLINICAL INVESTIGATOR, 1994, 72 (08): : 619 - 630
  • [7] TUMOR-SUPPRESSOR GENES AND THEIR ROLES IN BREAST-CANCER
    COX, LA
    CHEN, G
    LEE, EYHP
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 19 - 38
  • [8] THE MOLECULAR-BIOLOGY OF ESOPHAGEAL AND GASTRIC-CANCER AND THEIR PRECURSORS - ONCOGENES, TUMOR-SUPPRESSOR GENES, AND GROWTH-FACTORS
    STEMMERMANN, G
    HEFFELFINGER, SC
    NOFFSINGER, A
    HUI, YZ
    MILLER, MA
    FENOGLIOPREISER, CM
    HUMAN PATHOLOGY, 1994, 25 (10) : 968 - 981
  • [9] Molecular pathology of hemangiopericytomas accompanied by severe hypoglycemia: oncogenes, tumor-suppressor genes and the insulin-like growth factor family
    K. Pavelić
    T. Čabrijan
    R. Hrašćan
    M. Vrkljan
    M. Lipovac
    S. Kapitanović
    K. Gall-Trošelj
    M. Herak Bosnar
    A. Tomac
    B. Gršković
    N. Karapandža
    L. J. Pavelić
    B. Krušlin
    Š. Spaventi
    J. Pavelić
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 307 - 314
  • [10] Molecular pathology of hemangiopericytomas accompanied by severe hypoglycemia: oncogenes, tumor-suppressor genes and the insulin-like growth factor family
    Pavelic, K
    Cabrijan, T
    Hrascan, R
    Vrkljan, M
    Lipovac, M
    Kapitanovic, S
    Gall-Troselj, K
    Bosnar, MH
    Tomac, A
    Grskovic, B
    Karapandza, N
    Pavelic, LJ
    Kruslin, B
    Spaventi, S
    Pavelic, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (06) : 307 - 314